Skip to main content

Histrelin Implant

Last Updated: September 24, 2021
Status: Resolved

Products Affected - Description
    • Vantas subcutaneous implant, Endo Pharmaceuticals, 50 mg, kit, NDC 67979-0500-01 - discontinued
Reason for the Shortage
    • Endo discontinued Vantas in September 2021.
    • Endo has Supprelin LA available.
Available Products
    • Supprelin LA subcutaneous implant, Endo Pharmaceuticals, 50 mg, kit, NDC 67979-0002-01

Updated

Updated September 24, 2021 by Leslie Jensen, PharmD, Drug Information Specialist. Created February 17, 2021 by Stephen Andrews, PharmD, BCPS, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.